Næste

Automatisk afspilning

Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL

9 Visninger • 08/09/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning